BAGSVAERD, DENMARK--(Marketwire - September 14, 2009) - Novo Nordisk A/S - Share
repurchase programme
On 7 August 2009 Novo Nordisk initiated its share repurchase
programme in accordance with the provisions of the European
Commission's regulation no 2273/2003 of 22 December 2003, also
referred to as the Safe Harbour rules.
Under the programme Novo Nordisk will repurchase B shares for an
amount up to DKK 2.4 billion in the period from 10 August 2009 to
18
December 2009.
Since the announcement as of 7 September 2009, the following
transactions have been made under the programme:
Number of Average purchase Transaction
shares price value, DKK
--------------------------------------------
Accumulated, last
announcement 1,521,000 479,133,986
7 September 2009 55,000 316.5500 17,410,250
8 September 2009 66,000 319.0900 21,059,940
9 September 2009 75,000 318.5030 23,887,725
10 September 2009 75,000 322.2300 24,167,250
11 September 2009 75,000 326.5450 24,490,875
Accumulated under
the programme 1,867,000 590,150,026
With the transactions stated above, Novo Nordisk owns a total of
26,703,808 treasury shares, corresponding to 4.3% of the share
capital. The total amount of shares in the company is 620,000,000
including treasury shares. Novo Nordisk is a healthcare company
and a world leader in diabetes care. In addition, Novo Nordisk has
a leading position within areas such as haemostasis management,
growth hormone therapy and hormone replacement therapy. Novo
Nordisk manufactures and markets pharmaceutical products and
services that make a significant difference to patients, the
medical profession and society. With headquarters in Denmark, Novo
Nordisk employs more than 27,900 employees in 81 countries, and
markets its products in 179 countries. Novo Nordisk's B shares are
listed on the stock exchanges in Copenhagen and London. Its ADRs
are listed on the New York Stock Exchange under the symbol 'NVO'.
For more information, visit novonordisk.com.
Company Announcement No 54 / 2009
This announcement was originally distributed by Hugin. The issuer
is
solely responsible for the content of this announcement.
Copyright © Hugin AS 2009. All rights reserved.
